Condition: Head and Neck Cancer · Lung Cancer · Sponsor: Rutgers, The State University of New Jersey
The purpose of the research is to evaluate a new schedule of alternating cycles of induction chemoimmunotherapy (chemotherapy plus pembrolizumab) and immunotherapy (pembrolizumab) alone for the initial treatment of patients with advanced lung or head and neck cancers.
This description comes directly from the study's public registry record.
Missak Haigentz, MD · 732-235-6031 · mh1472@cinj.rutgers.edu
Always discuss trial participation with your own doctor first.
| Trinitas Hospital and Comprehensive Cancer Center | Elizabeth, New Jersey, United States | Recruiting |
| Cancer Institute of New Jersey at Hamilton | Hamilton, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Jersey City | Jersey City, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Monmouth Medical Center Southern Campus | Lakewood, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Saint Barnabas Medical Center | Livingston, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Monmouth Medical Center | Long Branch, New Jersey, United States | Recruiting |
| RWJ Barnabas Health - Robert Wood Johnson University Hospital | New Brunswick, New Jersey, United States | Not Yet Recruiting |
| Rutgers Cancer Institute of New Jersey | New Brunswick, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Newark Beth Israel Medical Center | Newark, New Jersey, United States | Recruiting |
| Robert Wood Johnson Somerset Hospital | Somerville, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Community Medical Center | Toms River, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05358548